Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 52 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Case Report: Genotype-informed management after clinically necessary cytoreduction for giant recurrent gastric gastrointestinal stromal tumor with prior rupture and KIT exon 17 N822Y mutation
    Jianrui Rui, Chaoqiang Cai, Yongyuan Chen +8
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  2. HHLA2-KCTD12 axis: a potential mechanism regulating the biological functions of laryngeal squamous cell carcinoma
    Yue Yu, Jianqiang You, Xiaoye Wang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and PD-1 inhibitors for unresectable hepatocellular carcinoma: a meta-analysis
    Renbin Ouyang, Xiaocheng Li, Kun Huang +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  4. GSTP1 as a senescence-associated diagnostic candidate in prostate cancer: integrative bioinformatics and functional validation
    Houhe Li, Shuo Lu, Hua Wang +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Case Report: Coexpression of somatic EGFR, BRCA1, and BRCA2 mutations in metastatic non-small cell lung cancer
    Aaron Negin, Kush Sachdeva, Jared Weiss
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  6. Distinct prognostic impact of circumferential resection margin and adverse histologic features after intersphincteric resection for ultra-low rectal cancer following chemoradiotherapy: a retrospective cohort study.
    Jung Kyong Shin, Hee Cheol Kim, Woo Yong Lee +4
    Annals of surgical treatment and researchPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  7. Neutrophil-to-Lymphocyte Ratio Is Associated with Disease Progression in a Surveillance Cohort of Patients with Branch-Duct IPMN
    Frederik J. Hansen, Peter Ewald, Luis Sorncharoen +12
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  8. Real-World Evaluation of the Immune Checkpoint Inhibitor Score (IChIS) in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
    İsmail Dilli, Engin Eren Kavak, Mehmetcan Atak +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  9. Latent psychological resilience profiles and their association with physical resilience in older patients after robot-assisted radical prostatectomy: a cross-sectional study
    Rong Liu, Xiang Xi, Xiao Ma +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  10. Ferroptosis-driven radio-immunosensitization: an emerging mechanistic framework for enhancing response to immune checkpoint inhibitor therapy
    Zhenghao Cao, Xudong Ao
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  11. Safety, efficacy, and biomarker analysis of HTMC0435 plus temozolomide in relapsed extensive-stage small-cell lung cancer: A phase Ib/II trial
    Sizhe Yu, Lei Gong, Jun Qian +13
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  12. Development and Validation of a Tool to Measure Documented Health Care Encounter Time
    Ronald Chow, Sarah Bayrakdarian, Olivera Gojsevic +23
    JAMA Network OpenPeer-reviewedCC BY 4.0OncologyCrossref
  13. Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition
    Clayton W. Kosonocky, Alex M. Abel, Aaron L. Feller +97
    Molecular Systems BiologyPeer-reviewedCC BY 4.0Full text12 citedOncologyCrossrefOpenAlexPMC
  14. Induced mismatch repair deficiency: a hypothesis for the transient and reversible sensitization of mismatch repair-proficient tumors to Immune checkpoint blockade
    Paulo P. Assumpção, Alessandro Leal, Williams Fernandes Barra +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  15. The Osteosarcoma Tumor Microenvironment: Supportive of Tumor Progression, Hostile to Immunity, but Therapeutically Targetable.
    Lidia Tarone, Irene Fiore Merighi, Elisa Tirtei +4
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  16. Clinical and Treatment-Related Factors Associated with Neutrophil Recovery After Bloodstream Infection in Acute Leukemia: A Competing-Risk Analysis.
    Krzysztof Gawronski, Nadia Hussein, Piotr Rzepecki +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  17. Radiation-Induced Contrast Enhancement After Proton Therapy for Paediatric Brain Tumours: Association with Variable Relative Biological Effectiveness and Linear Energy Transfer.
    Julian Brack, Valon Gllareva, Bastian von Nettelbladt +12
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  18. Multi-Omics and Liquid Biopsy Integration for Precision Stratification of Breast Cancer.
    Dheeraj Sharma, Shriyansh Srivastava, Sathvik Belagodu Sridhar +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  19. Machine learning model for the prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer.
    Eva Reisig, Lie Cai, Maria Müller +2
    BMC cancerPeer-reviewedCC BYFull textOncologyEurope PMC
  20. Waterpipe Smoke Condensate Impairs p53 Nuclear Localization in Association with HIF-1α Stabilization
    Husam Nawafleh, Jerome Thiery, Yehya Elsayed +3
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  21. Are quality of life data reported in clinical trials evaluating CAR T cells in hematologic malignancies?
    Julie Bouaziz-Bohbot, Lionel Karlin, Gilles A Salles +1
    Hematology, transfusion and cell therapyPeer-reviewedCC BYFull textOncologyEurope PMC
  22. Ectopic rabphilin-3A expression in lung adenocarcinoma associated with paraneoplastic arginine vasopressin deficiency during anti-PD-L1 therapy: a case report.
    Haruki Fujisawa, Yosuke Eguchi, Naoko Iwata +8
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  23. Role of Radiotherapy After Breast-Conserving Surgery in T1-2N0M0 Luminal (HR+/HER2-) Breast Cancer Stratified by Tumor Quadrant Location.
    Yajing Huang, Hao Wu
    Medical science monitor : international medical journal of experimental and clinical researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  24. Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers.
    Qiaoyan Qu, Jintan Xiao, Bingjian Zhao +1
    Neoplasia (New York, N.Y.)Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  25. Cell-delivered CD3×CD19 T-cell engager by STAb-T19 cells mediates leukemia clearance with limited systemic exposure.
    Laura Sanz-Ortega, Elena Barba-Sarasúa, Ivana Zagorac +6
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC